# Daniel E. Singer

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/daniel-e-singer/

## Facts

| Field | Value |
| --- | --- |
| Citations | 71,597 |
| Field | Atrial Fibrillation Management and Outcomes |
| h-index | 123 |
| i10-index | 349 |
| Last Known Institution | Harvard University |
| OpenAlex ID | https://openalex.org/A5020290782 |
| ORCID iD | https://orcid.org/0000-0001-6145-4848 |
| Works | 624 |

## Researcher papers

Showing 12 of 15.

- [Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation](https://scholariq.org/papers/rivaroxaban-versus-warfarin-in-nonvalvular-atrial-fibrillation/)
- [Prevalence of Diagnosed Atrial Fibrillation in Adults](https://scholariq.org/papers/prevalence-of-diagnosed-atrial-fibrillation-in-adults/)
- [Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult Population](https://scholariq.org/papers/estimates-of-current-and-future-incidence-and-prevalence-of-atrial-fibrillation/)
- [Antithrombotic Therapy for Atrial Fibrillation](https://scholariq.org/papers/antithrombotic-therapy-for-atrial-fibrillation/)
- [A New Risk Scheme to Predict Warfarin-Associated Hemorrhage](https://scholariq.org/papers/a-new-risk-scheme-to-predict-warfarin-associated-hemorrhage/)
- [Antithrombotic Therapy in Atrial Fibrillation](https://scholariq.org/papers/antithrombotic-therapy-in-atrial-fibrillation/)
- [The Effect of Warfarin and Intensity of Anticoagulation on Outcome of Intracerebral Hemorrhage](https://scholariq.org/papers/the-effect-of-warfarin-and-intensity-of-anticoagulation-on-outcome-of/)
- [Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment](https://scholariq.org/papers/prevention-of-stroke-and-systemic-embolism-with-rivaroxaban-compared-with/)
- [Advanced Age, Anticoagulation Intensity, and Risk for Intracranial Hemorrhage among Patients Taking Warfarin for Atrial Fibrillation](https://scholariq.org/papers/advanced-age-anticoagulation-intensity-and-risk-for-intracranial-hemorrhage/)
- [Death and Disability from Warfarin-Associated Intracranial and Extracranial Hemorrhages](https://scholariq.org/papers/death-and-disability-from-warfarin-associated-intracranial-and-extracranial/)
- [Gender Differences in the Risk of Ischemic Stroke and Peripheral Embolism in Atrial Fibrillation](https://scholariq.org/papers/gender-differences-in-the-risk-of-ischemic-stroke-and-peripheral-embolism-in/)
- [Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation](https://scholariq.org/papers/impact-of-proteinuria-and-glomerular-filtration-rate-on-risk-of-thromboembolism/)

## Researcher topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management-2/)
- [Acute Ischemic Stroke Management](https://scholariq.org/topics/acute-ischemic-stroke-management/)
- [Cardiac Arrhythmias and Treatments](https://scholariq.org/topics/cardiac-arrhythmias-and-treatments/)
- [Intracerebral and Subarachnoid Hemorrhage Research](https://scholariq.org/topics/intracerebral-and-subarachnoid-hemorrhage-research/)

## Researcher university

- [Harvard University](https://scholariq.org/institutions/harvard-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.